Pure Global Acquires Creditor Protection
Pure Global Cannabis (TSXV: PURE) announced this evening that it has received creditor protection as of March 19, 2020 following an application made by the company for protection under the Companies’ Creditor Arrangement Act. The granting of creditor protection was viewed by the firm as the best method of maximizing stakeholder value while addressing near […]
CloudMD Sees $2.3 Million First Tranche Of Placement Close
As previously indicated, CloudMD Software & Services (CSE: DOC) has closed the first tranche of its private placement for $2.3 million. Funds raised are expected to be put towards capital expenditures and general working capital. In connection with the offering, CloudMD has issued a total of 4,875,449 units at a price of $0.48, for gross […]
RavenQuest Edmonton Facility Sees Cannabis License Revoked
RavenQuest BioMed (CSE: RQB) has lost its license to cultivate cannabis for its Alberta Green Biotech subsidiary. The firm announced this morning that the company has received a notification from Health Canada for the intention to revoke the license. The revocation of the license is the result of the firm losing access to its Edmonton […]
Auxly Cannabis Announces Changes to Executive Team
Auxly Cannabis Group Inc (TSXV: XLY) has made changes to its executive team regarding the position of Chief Operating Officer. Auxly’s Chief Operation Officer, Jeff Tung has resigned effective immediately; however, the company has appointed another member to its executive team. Alan Cooke will now be taking the position of Vice President, Domestic and International […]
Harvest One CEO Resigns From Firm
In the latest shake up to management teams within the Canadian cannabis space, Harvest One Cannabis (TSXV: HVT) announced late last night that chief executive officer Grant Froese has resigned from his role, as well as a director, effective immediately. The resignation follows an ongoing strategic review that’s been conducted by the company as it […]
Kalytera Therapeutics Provides Update On Acquisition of Stero Biotechs
Kalytera Therapeutics Inc (TSXV: KLY) has released an update on the acquisition terms regarding the planned purchase Israeli company Stero Biotechs Ltd. As announced prior, Kalytera will purchase all Stero shares, with an initial $15 million USD of Kalytera common shares paid at closing- which account for approximately 37.5% of all the company’s outstanding common […]
Revive Explores Use of Bucillamine For Infectious Disease
Revive Therapeutics (CSE: RVV) announced this morning that it has applied for a provisional patent related to that of the drug Bucillamine as a potential novel treatment for infectious diseases including influenza and the novel coronavirus, also known as COVID-19. This isn’t the first time that the company has explored uses for that of Bucillamine, […]
Cronos Group Subject Of SEC Inquiry
This evening, MarketWatch reporter Max Cherney broke the story that Cronos Group (TSX: CRON) (NASDAQ: CRON) has received inquiries from that of the Securities and Exchange Commission related to its revenue recognition practices. The news follows internal investigations conducted by the issuer itself related to certain revenues that were recognized throughout 2019. As per the […]
Horvath Leaves Role As CEO At Green Growth Brands
Green Growth Brands (CSE: GGB) released a corporate update this evening, identifying that chief executive officer Peter Horvath has left the company immediately, which includes departing from his role as a director on the firms board. A reason was not provided for Horvath’s departure from Green Growth Brands. Taking his place will be that of […]
Champignon Brands To Acquire Biotech Firm Novo Formulations
Champignon Brands (CSE: SHRM) announced today that they have signed a definitive agreement to acquire that of Novo Formulations Ltd. Novo is a biotechnology focused firm that is currently developing novel and innovative delivery systems for the pharmaceutical and nutraceutical industries. The acquisition of Novo and their delivery systems platform and R&D advancements is anticipated […]